about
Intra-arterial chemoradiotherapy for head and neck cancerClinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology GroupPrognostic factors for survival in patients with high-grade meningioma and recurrence-risk stratification for application of radiotherapy.Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) systemOlfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomographyClinical outcomes of stereotactic body radiotherapy for patients with lung tumors in the state of oligo-recurrence.A Retrospective Study of G-Tube Use in Japanese Patients Treated with Concurrent Chemoradiotherapy for Hypopharyngeal Cancer.Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer.Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy.Evaluation of inter-observer variability of bladder boundary delineation on cone-beam CT.Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.Prospective phase II study of image-guided local boost using a real-time tumor-tracking radiotherapy (RTRT) system for locally advanced bladder cancerAnalysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markersReal-time 4-D radiotherapy for lung cancer.Effectiveness of superselective intra-arterial chemoradiotherapy targeting retropharyngeal lymph node metastasis.Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTVā©¾100cc.What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy.Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience.Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience.Intrafractional Baseline Shift or Drift of Lung Tumor Motion During Gated Radiation Therapy With a Real-Time Tumor-Tracking System.Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702).Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience.Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC).Reduction of bed rest time after transfemoral noncardiac angiography from 4 hours to 2 hours: a randomized trial and a one-arm study.The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.Hypofractionated radiotherapy boost for dose escalation as a treatment option for high-grade spinal cord astrocytic tumor.Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.[18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer.Management of vestibular schwannoma by fractionated stereotactic radiotherapy and associated cerebrospinal fluid malabsorption.Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system.The effect of tumor location and respiratory function on tumor movement estimated by real-time tracking radiotherapy (RTRT) system.Real-time tumor-tracking radiotherapy for adrenal tumors.How much margin reduction is possible through gating or breath hold?Three-dimensional intrafractional motion of breast during tangential breast irradiation monitored with high-sampling frequency using a real-time tumor-tracking radiotherapy system.Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation.
P50
Q26781184-2B05399D-A855-415B-8400-D4CB8DB997F2Q30834087-B77D66F1-E4FE-4B93-8571-8926335364D1Q33582628-4C8E5B54-1658-49BA-B5DF-4B867CF29DE3Q33599285-A0676EA1-DDF6-461C-AA17-1EBF145FDB1FQ33672832-86E7704F-3B0E-43EA-84FF-E3B5164D21DBQ35492794-25BD2792-1119-47DB-A853-8DCE4998C33BQ36101987-5F2BAF39-D973-43E3-A014-505833B36BEDQ36111256-C0BA5439-807F-4B27-8590-C2DE08DEB34AQ36734816-25630C67-46C8-49CE-8254-240DD7A5D0DEQ36767674-8EC8940D-CF3E-42E1-AB8A-169F40E6BD43Q37053632-39305EB6-91AF-4146-83D1-F7644DA3B571Q37385259-90BE53C7-4278-442A-A161-12D84E2A961BQ37430823-2700B024-D3EC-4E83-84BF-F255A7BCFADAQ37676862-F88DF23D-CE7D-4A8D-B305-E1DB2557600FQ37939960-7450273E-47D9-44DA-B0E7-E7B4CE3B163FQ38732532-EDDD975C-E292-4553-89AE-0E08667689B0Q39087641-97807C4E-C8DE-480B-B00C-97D49FE58A9DQ39231208-85A6B61D-510C-4E3D-B3AA-EA00B47836CEQ39246217-9ACF4857-611B-42FC-AB29-B94AEB332A8EQ39960135-D5783EC4-E187-477A-9015-657A5DE18BA8Q40174952-022212EF-C226-4ACB-BA1F-B79653D072A8Q40307501-75E303BB-4604-4FF1-BEE6-DDC97F4FFC5FQ40669964-5EA29138-D92D-4420-85EA-D136A66F5187Q41274960-6E14EEF0-0382-47BA-99AF-3EBFE52C7001Q41625534-CE79B1EF-88F5-4601-A450-83D1BDF0A4B7Q43601119-47BCC687-4A63-47CA-9E8B-F323721DDCBCQ43908881-6116C48C-AA7F-4C7E-8681-9F6ADD415D70Q44205415-A21EF03B-BF6A-4FFE-A0D6-3355134ABFD1Q44366262-9BA27BC2-E954-4877-A948-613AA2D5493CQ44532078-54EC2A1B-FC2A-4797-8A0F-6E5F30F27CD6Q45136378-3A2703A4-A99F-4B4C-841F-2FC69002D950Q45175748-9EB50008-9EED-4A28-9B7B-55EF9BA6C87AQ47178469-F1319838-38DF-4A35-AFB8-C93E01804DAAQ47742933-0C7DC1DE-0981-4A0F-A0AA-3E14552A7CFDQ47747589-E04512B7-4E82-4EEC-8EA0-5C47FB8AFFE3Q47831201-B6129EC0-3550-46DE-8D2D-5415BAB7C263Q47996221-FDBDEE3E-6303-4847-BF0C-09520F827043Q48229812-72984454-C2FA-4881-94D4-6239F8A4D56CQ48318260-B89C9B73-5A59-4B3A-8324-B4BC2365284EQ48419607-5C0320C3-D98A-40B1-8EB2-DD3FC567504D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
Õ°Õ„ÕæÕ”Õ¦ÕøÕæÕøÕ²
@hy
name
Rikiya Onimaru
@ast
Rikiya Onimaru
@en
Rikiya Onimaru
@es
Rikiya Onimaru
@nl
Rikiya Onimaru
@sl
type
label
Rikiya Onimaru
@ast
Rikiya Onimaru
@en
Rikiya Onimaru
@es
Rikiya Onimaru
@nl
Rikiya Onimaru
@sl
prefLabel
Rikiya Onimaru
@ast
Rikiya Onimaru
@en
Rikiya Onimaru
@es
Rikiya Onimaru
@nl
Rikiya Onimaru
@sl
P1053
C-9805-2012
P106
P21
P31
P3829
P496
0000-0002-4768-2358